Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Pandoraon Jun 20, 2022 12:00pm
87 Views
Post# 34768928

RE:RE:RE:RE:Contrast media shortage

RE:RE:RE:RE:Contrast media shortage
jopatclo wrote:
freerider1985 wrote: That's my point VMS don't need any contrast media to scan its non-invasive .So this can be plus for ventripoint in colaboration with GE.


YES it will be a big plus for VPT and health for those who need it badly...
read a good comment on another forum...

 My humble opinion only as a six figure share holder which I only disclose so folks know I have skin in the company. VPT as a "stock" play is going to disappoint every day. Especially in a bear market that is going to continue to fall off a cliff. What we are seeing today is nothing, it is getting much worse. There is no price sustainability in the market. Even if VPT announces 10 sales or 30 or 50 the stock may bounce but too many will sell on that bounce. For those looking to make a life changing return (my hand raised) this company is doing everything right and everyday there is no "negative NR" puts us in a stronger position. They are in working partnerships, 15+ studies and at the beginning of their sales cycle with strong talent on board. And they have 2 years of cash and no debt. And they have 4.0 coming out. And if anyone has been reading anything on the mortality rates from Insurance providers you will be overwhelmed with the rates of death caused by heart failures. The CDC just published a staggering report on myocarditis in 12-24 year olds. Heart disease was the #1 killer before covid and heart disease is still the #1 killer but now we have young folks dying suddenly. VPT was made for such a time and the medical community will need it to help turn the tide. I am not going to tell anyone to be patient because it is your risk and your money but forget the trees (daily price movements) and look at the entire forest. And this is from someone who looks for the negative/risk in every company. My head and money is not in the clouds. Just stating facts.


https://crossroadsreport.substack.com/p/breaking-fifth-largest-life-insurance?s=r
<< Previous
Bullboard Posts
Next >>